(Q44535731)

3 December 2017

Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols (English)

1 reference

3 December 2017

0 references

3

1 reference

3 December 2017

Omar S Usmani

1

1 reference

3 December 2017

Martyn F Biddiscombe

series ordinal

2

1 reference

3 December 2017

S Richard Underwood

series ordinal

4

1 reference

3 December 2017

Peter J Barnes

series ordinal

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Journal of Applied Physiology

3 December 2017

1 reference

3 December 2017

95

1 reference

3 December 2017

5

1 reference

3 December 2017

2106-2112

1 reference

Standardization of Spirometry, 1994 Update. American Thoracic Society

3 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Localization of β-adrenoreceptors in mammalian lung by light microscopic autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Systemic effects of salbutamol and salmeterol in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

A system for the production and delivery of monodisperse salbutamol aerosols to the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Calculated deposition of inhaled particles in the airway generations of normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Aerosolization of protein solutions using thermal inkjet technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Dose-response effects of two sizes of monodisperse isoproterenol in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

The influence of lung deposition on clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Lung deposition and extremely slow inhalations of particles. Limited effect of induced airway obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

Clinical perspectives: role of the airway circulation in drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

The optimal particle size for β-adrenergic aerosols in mild asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00525.2003

10.1152/JAPPLPHYSIOL.00525.2003

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference